TAAR1 Agonism for Psychosis
What do we know about the efficacy, adverse events, and mechanisms of a new class of medications (called “Trace Amine Associated Receptor 1 agonists” or “TAAR1 agonists”) in treating psychosis?
Latest Research Reports
PsychosisTAAR1 Agonism for Psychosis
Plain Language Summary of a Systematic Review
AnxietyCognitive Bias Modification for Social Anxiety
Protocol for a living systematic review of human studies and meta-analysis.
PTSDThe Therapeutic Potential of Exercise in PTSD
Unravelling the mechanisms underlying the therapeutic potential of exercise in post-traumatic stress disorder (PTSD), a systematic review
Who we are?
A new living evidence resource of early phase research for research prioritisation in mental health.
It’s difficult for researchers, funders, people with lived experience, and others with an interest in mental health science to keep track of the ever-expanding literature. How can this information, which is published every day, all over the world, be gathered, analysed, and used effectively to design new research that makes a difference?
Our Partners
GALENOS Crowd
To assist GALENOS researchers in carrying out evidence synthesis activities (such as screening records and extracting data) we are collaborating with Cochrane Crowd and forming our own GALENOS Crowd. If you are interested in getting involved in mental health research with GALENOS then click below to find out more.
News & Blog
08 Sep. 2023
Announcing the Global Experiential Advisory Board – GLEAB
The number of research publications is increasing every day, in all scientific areas including mental health. This makes it increasingly more challenging for academics, health professionals and members of the public to read through all the new public...
05 Jul. 2023
Research Appreciation Day
This Wednesday the 5th of July is the inaugural 'Research Appreciation Day', a social media initiative to celebrate and recognise the ground-breaking work of health researchers.
09 Feb. 2024
TAAR1 Agonism for Psychosis
What do we know about the efficacy, adverse events, and mechanisms of a new class of medications (called “Trace Amine Associated Receptor 1 agonists” or “TAAR1 agonists”) in treating psychosis? In ord...
09 Oct. 2023
Trace Amine-Associated Receptor 1 Agonists For Psychosis: Protocol For A Living Systematic Review
Psychotic disorders affect around 1% of the population, and rank among the top 20 causes of disability worldwide.
14 Apr. 2023
What Are Ontologies and What Can They Be Used For?
Janna Hastings talks to the Human Behaviour-Change Project about ontologies.
16 May. 2024
Welcoming the New Chair and Vice-Chair of GLEAB
We are delighted to welcome a brand new Chair and Vice Chair of the GLEAB.
28 Mar. 2024
The Galenos Crowd Project
What is it and how can you get involved?
Explore Opportunities with Galenos
Galenos possesses an extensive repository of research and data pertaining to anxiety, depression, and psychosis. Have a question or want to learn more? We’d love to hear from you!